Tetrazole, 1,2,3-triazol, 1,2,4-triazol, 1,2,4-triazol, 1,2,4-oxadiazol, 1,3,4-oxadiazol and oxazol, from adenosine inhibitors； pharmacological synthesis and combination； cholesterol for the treatment of fibrosis, pruritus, cirrhosis, calcium, diabetes, kidney disease and pain.
CHRISTOPHER THOMSON,DAVID BEATTIE,URS BEATTIG,DARREN MARK LEGRAND,ANDREW STUART LISTER,JEFFREY MCKENNA,DAVID WILLIAM PEARCE,DAVID ANDREW SANDHAM,OLIVER ROSS STEWARD
申请号：
CL2016000117
公开号：
CL2016000117A1
申请日:
2016.01.15
申请国别(地区):
CL
年份:
2016
代理人:
摘要：
Nitrogenous Heterocyclic Compounds, i.e., Autotaxin inhibitors； Pharmaceutical composition, Pharmaceutical Combination； use for the treatment of a disease or condition selected from pruritus, fibrosis, cirrhosis, cancer, diabetes, Kidney Disease and pain.COMPUESTOS HETEROCICLICOS NITROGENADOS, INHIBIDORES DE AUTOTAXINA； COMPOSICION FARMACEUTICA； COMBINACION FARMACEUTICA； USO PARA EL TRATAMIENTO DE UNA ENFERMEDAD O AFECCION SELECCIONADA ENTRE FIBROSIS, PRURITO, CIRROSIS, CANCER, DIABETES, ENFERMEDADES RENALES Y DOLOR.
